JPMORGAN CHASE & CO - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 121 filers reported holding VIKING THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,167,850
-30.4%
557,168
+1.9%
0.00%0.0%
Q2 2023$8,859,299
+20191.6%
546,533
+20617.7%
0.00%
Q1 2023$43,660
+1091400.0%
2,638
+429.7%
0.00%
Q4 2022$4
-100.0%
498
-98.3%
0.00%
Q3 2022$80,000
-40.3%
29,008
-37.1%
0.00%
Q2 2022$134,000
+35.4%
46,085
+40.1%
0.00%
Q1 2022$99,000
-20.2%
32,893
+20.5%
0.00%
Q4 2021$124,000
-24.4%
27,287
+4.4%
0.00%
Q3 2021$164,000
+2.5%
26,135
-2.7%
0.00%
Q2 2021$160,000
-36.3%
26,872
-31.8%
0.00%
Q1 2021$251,000
+50.3%
39,423
+32.3%
0.00%
Q4 2020$167,000
+15.2%
29,800
+21.9%
0.00%
Q3 2020$145,000
-8.8%
24,442
+10.8%
0.00%
Q2 2020$159,000
+57.4%
22,052
+2.8%
0.00%
Q1 2020$101,000
-41.3%
21,455
+0.1%
0.00%
Q4 2019$172,000
+17.0%
21,4350.0%0.00%
Q3 2019$147,000
-1.3%
21,435
+20.3%
0.00%
Q2 2019$149,000
+0.7%
17,824
+20.1%
0.00%
Q1 2019$148,000
+26.5%
14,841
-3.1%
0.00%
Q4 2018$117,000
-44.0%
15,320
+27.5%
0.00%
Q3 2018$209,000
+148.8%
12,011
+35.8%
0.00%
Q2 2018$84,0008,8430.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders